✨ Free AI Report
Formation Bio: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Company Research Formation Bio
Company Research

Formation Bio: Business Overview, Financials & Competitive Analysis

Formation Bio (formerly TrialSpark) is an AI-native, tech-enabled pharmaceutical company that aims to radically accelerate drug development. The company operates by acquiring or in-licensing clinical-stage drug candid...

Analyst-debate audio for Formation Bio

AskCyborg analysts argue the bull and bear cases for Formation Bio across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
8/ 10Strong

Cyborg Score thesis

AI-native pharma company with proven clinical execution and strategic pharma partnerships positioned to capture structural...

Read the full analyst-debate transcript →
Industry Drug Discovery Services
3 named competitors
3 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: October 5, 2026
AI-Verified Research
30+ Page Report

Get the Latest Formation Bio Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Formation Bio Overview

Pro stress-test →

Formation Bio (formerly TrialSpark) is an AI-native, tech-enabled pharmaceutical company that aims to radically accelerate drug development. The company operates by acquiring or in-licensing clinical-stage drug candidates from biotech and pharmaceutical companies and advancing them through its proprietary technology platform, integrating software, AI, and streamlined clinical trial operations to reduce the time and cost of drug development.

Strategic Profile

Pro stress-test →

Its team and advisors have been involved in over 75 regulatory submissions as of May 2024, with over 45 drugs approved as of April 2025. The company recently entered a first-of-its-kind collaboration with OpenAI and Sanofi to build specialized AI models and tools, such as 'Muse', designed to automate and optimize patient recruitment and trial design.

Competitive Landscape

Pro stress-test →

Formation Bio competes in the AI-driven drug development space alongside players like Recursion Pharmaceuticals and Exscientia, but differentiates through its integrated clinical execution model (acquiring and developing drugs directly) rather than pure discovery focus. The company's asset acquisition strategy and operational efficiency platform position it between traditional biotech and emerging AI-native pharma companies.

Industry Context

Formation Bio operates in Drug Discovery Services.

Key facts

Founded: 2016 · Headquarters: New York, NY · Employees: 51-200

What the analysts stress-tested

The top findings that survived the multi-agent debate for Formation Bio.

  • Addresses clinical trials bottleneck: Formation Bio tackles a $3.2 trillion pharmaceutical industry constrained by rising R&D costs and lengthy timelines
  • Strong institutional backing: Series D (June 2024) led by a16z with significant Sanofi participation signals confidence in the AI-pharma thesis
+2 more stress-tested counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

  • April 2025Over 45 drugs approved across portfolio
  • June 2024Raised $372MM Series D financing led by Andreessen Horowitz with participation from Sanofi
  • +1 moreTrack every material event for Formation Bio as it happens. Explore monitoring →
Get alerted when Formation Bio has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

Recursion PlatformAI-powered drug discovery and development→Exscientia PlatformAI-driven drug discovery and optimization→InSilico MedicineAI platform for drug discovery and development→

Compare Formation Bio with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Formation Bio operates in Drug Discovery Services. See how the rest of the sector scores on the Cyborg framework.

Browse Drug Discovery Services research →
NEW · MCP server

Ask your AI assistant about Formation Bio

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Formation Bio and its top competitor on Cyborg Score”
“What did Formation Bio do this quarter?”
“Is Formation Bio a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg builds confidence

⚔

Analyst debate, not single-author opinion

Every report is stress-tested by a panel of AI analysts arguing across 11 dimensions. The output is the part of the case that survived pushback.

📊

Recalibrated weekly

The Cyborg Score is recomputed weekly against fresh data. Recent material developments are continuously tracked and surfaced.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The same company gets the same score from any analyst running the framework.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, news flow, and proprietary analyst signals. Read the methodology →

Frequently asked questions

What does Formation Bio do?+
Formation Bio (formerly TrialSpark) is an AI-native, tech-enabled pharmaceutical company that aims to radically accelerate drug development. The company operates by acquiring or in-licensing clinical-stage drug candid...
What is Formation Bio's Cyborg Score?+
Formation Bio has a Cyborg Score of 8/10 (Strong). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Formation Bio's main competitors?+
Named competitors include Recursion Platform, Exscientia Platform, InSilico Medicine. The full competitive landscape is in the AskCyborg report.
How can I get the full Formation Bio research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Formation Bio research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Formation Bio over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

Top-scored companies on AskCyborg

The strongest performers across the analyst-debate framework.

9Advantest Corporation9Anthropic9Apple Inc.9Applied Materials, Inc.9Arista Networks9Aritzia Inc.9ASML Holding N.V.9BAE Systems plc9Barrick Mining Corporation9Berkshire Hathaway Inc.